Oxford Drug Design raises £2.2 million bridge round backed by ACF Investors, o2h Ventures, Meltwind Advisory and the R42 group.

Health services Manufacturing Pharma Software Services

Investments

12 May 2022

Oxford Drug Design (company)

Health services Manufacturing Pharma Software Services

Total investments received (USD): 2.74m

Round value (USD): 2.74m

Round investors: Meltwind o2h Ventures ACF Investors R42 Group

Industry: Health services Manufacturing Pharma Software Services

Health services Marketplace Mobile Software Services

Investments 08 November 2022

Biotech Food Industry Manufacturing Software Services

Investments 06 November 2022

Health services Manufacturing

Investments 05 November 2022

AI (big data) Competitive Intelligence Health services Software Services

Investments 05 November 2022

Health services Mobile Social Network Software Services

Investments 05 November 2022